The challenges we have faced during the COVID-19 pandemic has required us to manage many aspects of clinical development differently. We have addressed many of these obstacles with creativity and flexibility – this has included a steep learning curve around the conduct of clinical trials during a pandemic.
The EUFEMED 2021 conference provides a unique opportunity to hear about the pandemic experience from regulators, sponsors and those working in CROs. We invite you to join us. At the meeting the clinical pharmacology community will discuss the impact of lessons we have learned and solutions we have developed on future work. Stakeholders will be excited to hear about the sophisticated and innovative technologies that are becoming increasingly relevant for sponsors.
We have developed an exciting and challenging programme that we expect to generate marked interest amongst our colleagues from across Europe. We have also developed an attractive range of opportunities for partners like yourself to initiate conversations with new and existing clients. Please find options that are available for you to engage with our community.